Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03057327
Other study ID # STU00204685
Secondary ID
Status Completed
Phase N/A
First received February 15, 2017
Last updated October 6, 2017
Start date March 1, 2017
Est. completion date July 27, 2017

Study information

Verified date October 2017
Source Northwestern University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The proposed study is a pilot and feasibility study designed to develop materials to enhance early detection of melanomas among women at risk to develop melanoma due to indoor tanning, having a family history of melanoma or a personal history of melanoma.

The hypothesis of this study is that women, who are engaged in health promotion by having mammograms, will be able to assess the personal relevance of skin self-examination (SSE), be interested in learning about SSE and able to implement SSE while they are partially disrobed in the privacy of the changing room in the mammogram facility.


Description:

After patients complete the mammogram, they return to the changing room and put on their clothing. After exiting the changing room in the Lynn Sage Comprehensive Breast Center of Northwestern Medicine/Prentice Women's Hospital and as they are preparing to leave, a research assistant (RA) will screen potential participants to acquire a randomly selected convenience sample of eligible participants (n=200). The first 100 eligible subjects will be asked if they regularly check their moles for concerning features. If the response is yes, then they will be asked if they have found concerning moles and what they did next. Verbal assent will be obtained.

Then the SSE materials will be placed into the changing rooms and the next 100 eligible subjects will be surveyed. The women, who found the information relevant, will be asked if they chose to check their skin while in the changing room. The skin location checked and use of the SSE kit will be ascertained. Women will be asked if they think they have a concerning mole. If the woman does not find a concerning mole, she will be asked if she intends to check her skin again. In addition, she will be asked if she intends to check the skin of family members. Women will be invited to take a brochure to help implement SSE.

The screening questions are as follows:

1. During your visit for mammography, did you notice any information about checking your skin for melanoma?

___Yes __ No

2. Did you think this applied to you? ___Yes __ No

3. If no, why not? (open ended)

4. If yes, why? (open ended)

5. Did you check your skin? (If no, please proceed to question #8)

___Yes __ No

6. If yes, did you notice any concerning moles?

- Yes __ No

7. If yes, may we contact you by telephone or email in 2 weeks to see if you have made an appointment to see a dermatologist?

___Yes __ No If yes, which way do you prefer to be contacted?

Phone _________________________(Number) Email _________________________ (Address)

8. If no, will you consider checking your skin in the future?

___Yes __ No

9. If yes, may we contact you by telephone or email in 2 weeks to see if you have checked your skin for any concerning moles?

___Yes __ No If yes, which way do you prefer to be contacted?

Phone _________________________(Number) Email _________________________ (Address)

10. If you found any concerning moles, did you make an appointment to see a dermatologist.

- Yes __ No

The RA will record the responses. Women who checked their skin ,either today or in about 2 weeks, will be invited to participate in a survey about skin location(s) checked, use of the SSE kit, and their decision about the spot on the skin.


Recruitment information / eligibility

Status Completed
Enrollment 560
Est. completion date July 27, 2017
Est. primary completion date July 27, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria:

- Qualitative research: structured interview Women 18 years of age and older, who are waiting to have a mammogram Women agree to a structured interview regarding knowledge of melanoma and awareness of melanoma risk.

Following development of a draft of a brochure, women will agree to review a draft and provide comment during a 5 minute interview

- Qualitative research: focus group Women 18 years of age and older Women with a history of regular mammograms Women with a history of indoor tanning, a personal history of skin cancer, and/or a family history of skin cancer Women willing to participate in a 60 minute focus group to assess materials to be provided during the mammogram experience

- Quantitative research

Women 18 years of age and older who respond positively to the three screening questions:

Noticed information about checking your skin for melanoma. Thought this information was applicable to them. Checked skin or will consider checking skin in the future.

Exclusion Criteria:

- Women who are unable to see to read a newspaper, unable to read English, and who have cognitive impairment causing problems with functioning at a sixth grade reading level or inability to speak.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Improve awareness of checking moles
Intervention: Improve awareness Each of the eight changing rooms will have a large mirror that can be used to see the face and chest. Each room will be equipped with a poster, brochures and the SSE kit consisting of the laminated card with a ruler on one edge and the magnifying lens will be fastened to the wall on a cord. Provide education The subject may chose to read the poster and a brochure. c) A woman research assistant will perform in-person exit interviews with participants to ascertain if women noticed the poster, and found the information relevant.
Other:
Comparator
Prior to placing the intervention materials into the changing rooms, 100 eligible subjects will be asked if they regularly check their moles for concerning features. If the response is yes, then they will be asked if they have found concerning moles and what they did next.

Locations

Country Name City State
United States Northwestern Memorial Hospital Chicago Illinois

Sponsors (1)

Lead Sponsor Collaborator
Northwestern University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Management of decision Made appointment to see a doctor about the mole 2 weeks
Primary Performance of SSE Checked Moles 4 weeks
Secondary Questionnaire to identify concerning moles Found Concerning mole 2 weeks